search
Back to results

Lower Extremity Peripheral Arterial Disease and Exercise Ischemia (CLASH)

Primary Purpose

Peripheral Arterial Diseases, Intermittent Claudication

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Subsequent walking performance
Sponsored by
Rennes University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Peripheral Arterial Diseases

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥ 18 years old
  • Insured under the French social security system (according to French law)
  • Presence of lower-extremity peripheral artery disease, defined by:

    • A resting ankle-brachial index (ABI) ≤ 0.90
    • OR if resting ABI > 0.90 and < 1.00, a decrease in recovery ankle systolic pressure or in recovery ABI from treadmill exercise higher than 30% or 20%, respectively (AHA recommendations).
    • OR if resting ABI > 1.40, a toe pressure index ≤ 0.70
  • Maximal walking distance on treadmill (3.2 km/h, 10% grade) < 500m (a)
  • Complain of exertional lower limbs pain that can begin or not at rest, causes the participant to stop walking and relieves or lessens within 10 minutes of rest (assessed using the San Diego questionnaire AND confirmed during treadmill testing) (b)

    1. As assessed during the medical appointment.
    2. According to our inclusion criteria, patients' leg symptoms that fell within the following leg symptom categories could be included in the study:

    i) Intermittent claudication. Patients that experience exertional calf pain that does not begin at rest and that forces them to stop walking and that relieves or lessens within 10 minutes of rest; ii) Atypical exertional leg pain/stop. This category can encompass diverse situations of exertional leg symptoms. In the present study, patients in this category were included if they experience exertional pain that does not begin at rest and that forces them to stop walking, but that do not involve only the calf(s) but also thigh(s) and/or buttock(s). Further, the exertional leg pain relieves or lessens within 10 minutes of rest; iii) Leg pain on exertion and rest. In this category, patients sometimes experience exertional leg pain at rest when they are standing still or sitting. On exertion, patients also experience a walking pain as described above. As reminded by Criqui et al., this category of patients with "pain at rest" should not be confused with patients that experience "rest pain", which usually refers to patients with such severe advanced PAD that ischemic pain is present even at rest. Patients with ischemic rest pain were not included in the study.

Non-Inclusion criteria

  • Exercise limitation due to symptoms not related to an arterial insufficiency in the lower limbs (e.g., dyspnea, angina pectoris)
  • Contraindication for walking (Abdominal aortic aneurysm > 4 cm)
  • Myocardial infarction and no stroke in the last 3 months
  • Critical limb ischemia, amputation.
  • Pregnant women
  • Adult subject to legal protection (guardianship or tutelage measure) and persons deprived from their liberty (according to French law).
  • Patient living more than 50 km from the university hospital
  • Patient unable to understand the instructions of the study

Sites / Locations

  • Rennes University Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Subsequent walking performance

Arm Description

Subsequent walking performance

Outcomes

Primary Outcome Measures

Coefficient of determination between the recovery duration and subsequent walking performance, obtained from individual regression analyses.
Coefficient of determination between the recovery duration and subsequent walking performance, obtained from individual regression analyses.

Secondary Outcome Measures

Coefficient of determination determined from different curves fitting
Coefficient of determination determined from different curves fitting

Full Information

First Posted
January 14, 2014
Last Updated
May 22, 2023
Sponsor
Rennes University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02041169
Brief Title
Lower Extremity Peripheral Arterial Disease and Exercise Ischemia
Acronym
CLASH
Official Title
Lower Extremity Peripheral Arterial Disease and Exercise Ischemia: Walking Capacity Variability, Pain Evolution and Pathophysiological Responses. The CLASH Study.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
September 2014 (Actual)
Primary Completion Date
July 2018 (Actual)
Study Completion Date
September 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Rennes University Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Lower extremity peripheral arterial disease (LEPAD) is a highly prevalent chronic disease. Cardiovascular mortality of LEPAD patients at five years ranges between 18 to 30%. LEPAD is primarily caused by atherosclerosis that induces an inadequate blood flow to meet the tissues demand due to the narrowing of the arteries. An aggravation of the arterial lesions in LEPAD patients induces a worsening of patients' symptoms and a severe limitation of their walking capacity, contributing to an impairment of their quality of life. Despite maintaining a sufficient walking activity is essential for these patients, LEPAD patients lower their physical activity, which worsen the disease and potentially contribute to increase the risk of cardiovascular events and deaths. In a recent study in LEPAD patients, we showed, from a one hour GPS recording, a high variability of the patients' walking capacity (i.e., walking distances between two stops induced by lower limbs pain). Results suggested that in most patients previous stop duration before each walk was a predictor parameter of this walking variability. Whether there is an optimal or minimal recovery time influencing the walking capacity in LEPAD patients has never been studied. This study is a prospective, cross-sectional study in exercise pathophysiology. The main goal is to determine, following a walk that induces ischemia, the influence of the recovery duration on the subsequent walking performance in LEPAD patients. Secondary goals are : To determine the nature of the relationship between the recovery duration and subsequent walking performance. To study the relationship between exercise ischemia, pain evolution and previous recovery duration. To determine whether the experimental procedure influence the determination of an optimal of minimal recovery duration. To study the influence of recovery duration on walking capacity from community-based measurement.
Detailed Description
It is expected to determine for the first time an optimal recovery duration that would maximize the walking capacity of LEPAD patients. In the medium term : To give indications to the LEPAD patients to manage their pain in the community without lower their physical activity. To limit the functional decline of LEPAD patients. To influence the quality of life and cardiovascular mortality. This would deserve furthers studies.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peripheral Arterial Diseases, Intermittent Claudication

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
23 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Subsequent walking performance
Arm Type
Experimental
Arm Description
Subsequent walking performance
Intervention Type
Other
Intervention Name(s)
Subsequent walking performance
Intervention Description
Subsequent walking performance
Primary Outcome Measure Information:
Title
Coefficient of determination between the recovery duration and subsequent walking performance, obtained from individual regression analyses.
Description
Coefficient of determination between the recovery duration and subsequent walking performance, obtained from individual regression analyses.
Time Frame
32 days
Secondary Outcome Measure Information:
Title
Coefficient of determination determined from different curves fitting
Description
Coefficient of determination determined from different curves fitting
Time Frame
32 days
Other Pre-specified Outcome Measures:
Title
Coefficient of correlation between the level of ischemia during recovery and exercise ischemia and pain occurrence during subsequent walking
Description
Coefficient of correlation between the level of ischemia during recovery and exercise ischemia and pain occurrence during subsequent walking
Time Frame
32 days
Title
Coefficient of correlation between the optimal recovery duration measured on the laboratory and measures from community-based measurements.
Description
Coefficient of correlation between the optimal recovery duration measured on the laboratory and measures from community-based measurements
Time Frame
32 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years old Insured under the French social security system (according to French law) Presence of lower-extremity peripheral artery disease, defined by: A resting ankle-brachial index (ABI) ≤ 0.90 OR if resting ABI > 0.90 and < 1.00, a decrease in recovery ankle systolic pressure or in recovery ABI from treadmill exercise higher than 30% or 20%, respectively (AHA recommendations). OR if resting ABI > 1.40, a toe pressure index ≤ 0.70 Maximal walking distance on treadmill (3.2 km/h, 10% grade) < 500m (a) Complain of exertional lower limbs pain that can begin or not at rest, causes the participant to stop walking and relieves or lessens within 10 minutes of rest (assessed using the San Diego questionnaire AND confirmed during treadmill testing) (b) As assessed during the medical appointment. According to our inclusion criteria, patients' leg symptoms that fell within the following leg symptom categories could be included in the study: i) Intermittent claudication. Patients that experience exertional calf pain that does not begin at rest and that forces them to stop walking and that relieves or lessens within 10 minutes of rest; ii) Atypical exertional leg pain/stop. This category can encompass diverse situations of exertional leg symptoms. In the present study, patients in this category were included if they experience exertional pain that does not begin at rest and that forces them to stop walking, but that do not involve only the calf(s) but also thigh(s) and/or buttock(s). Further, the exertional leg pain relieves or lessens within 10 minutes of rest; iii) Leg pain on exertion and rest. In this category, patients sometimes experience exertional leg pain at rest when they are standing still or sitting. On exertion, patients also experience a walking pain as described above. As reminded by Criqui et al., this category of patients with "pain at rest" should not be confused with patients that experience "rest pain", which usually refers to patients with such severe advanced PAD that ischemic pain is present even at rest. Patients with ischemic rest pain were not included in the study. Non-Inclusion criteria Exercise limitation due to symptoms not related to an arterial insufficiency in the lower limbs (e.g., dyspnea, angina pectoris) Contraindication for walking (Abdominal aortic aneurysm > 4 cm) Myocardial infarction and no stroke in the last 3 months Critical limb ischemia, amputation. Pregnant women Adult subject to legal protection (guardianship or tutelage measure) and persons deprived from their liberty (according to French law). Patient living more than 50 km from the university hospital Patient unable to understand the instructions of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Guillaume MAHE, MD
Organizational Affiliation
Rennes University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rennes University Hospital
City
Rennes
State/Province
Brittany
ZIP/Postal Code
35033
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
26173488
Citation
de Mullenheim PY, Chaudru S, Mahe G, Prioux J, Le Faucheur A. Clinical Interest of Ambulatory Assessment of Physical Activity and Walking Capacity in Peripheral Artery Disease. Scand J Med Sci Sports. 2016 Jul;26(7):716-30. doi: 10.1111/sms.12512. Epub 2015 Jul 15.
Results Reference
result
PubMed Identifier
31271680
Citation
Chaudru S, Jehannin P, de Mullenheim PY, Klein H, Jaquinandi V, Mahe G, Le Faucheur A. Using wearable monitors to assess daily walking limitations induced by ischemic pain in peripheral artery disease. Scand J Med Sci Sports. 2019 Nov;29(11):1813-1826. doi: 10.1111/sms.13511. Epub 2019 Jul 31.
Results Reference
result
PubMed Identifier
29125051
Citation
Donnou C, Chaudru S, Stivalet O, Paul E, Charasson M, Selli JM, Mauger C, Chapron A, Le Faucheur A, Jaquinandi V, Mahe G. How to become proficient in performance of the resting ankle-brachial index: Results of the first randomized controlled trial. Vasc Med. 2018 Apr;23(2):109-113. doi: 10.1177/1358863X17740993. Epub 2017 Nov 10.
Results Reference
result
PubMed Identifier
33982591
Citation
de Mullenheim PY, Rouviere L, Emily M, Chaudru S, Kaladji A, Mahe G, Le Faucheur A. "Should I stay or should I go now?" Recovery time effect on walking capacity in symptomatic peripheral artery disease. J Appl Physiol (1985). 2021 Jul 1;131(1):207-219. doi: 10.1152/japplphysiol.00441.2020. Epub 2021 May 13.
Results Reference
result

Learn more about this trial

Lower Extremity Peripheral Arterial Disease and Exercise Ischemia

We'll reach out to this number within 24 hrs